← Eichor
Condition: Respiratory Syncytial Virus Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Respiratory Syncytial Virus Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )
Phase N/A · 1 location(s) · Tam Anh Research Institute · NCT07239583A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Partici
Phase 2 · 11 location(s) · SynAct Pharma Aps · NCT07633288Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
Phase 3 · 15 location(s) · University of Alabama at Birmingham · NCT05026749Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract In
Phase 3 · 1 location(s) · Kexing Biopharm Co., Ltd. · NCT06363370Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
Phase 3 · 8 location(s) · MAXVAX Biotechnology Limited Liability Company · NCT07272434COVID-19 Impact on RSV Emergency Presentations
Phase N/A · 1 location(s) · University Hospitals, Leicester · NCT04959734Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults
Phase 1 · 5 location(s) · Clover Biopharmaceuticals USA, LLC · NCT06843317Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute
Phase 1/Phase 2 · 3 location(s) · PEACHES BIOTECH · NCT06684379Peginterferon α-2b Injection for the Treatment of Pediatric RSV Bronchiolitis
NA · 3 location(s) · Children's Hospital of Soochow University · NCT06827249Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
Phase 2 · 1 location(s) · Johns Hopkins University · NCT07050732A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of
Phase 2 · 83 location(s) · Shionogi · NCT07214571Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease
NA · 6 location(s) · AstraZeneca · NCT06851806Epidemiological Characteristics and Clinical Burden of RSV Infection in Children Under 24 Months in Ho Chi Minh City (20
Phase N/A · 3 location(s) · Tam Anh Research Institute · NCT07640581A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
Phase 3 · 5 location(s) · Pfizer · NCT07543380Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older.
Phase 1/Phase 2 · 1 location(s) · Ab&B Bio-tech Co., Ltd.JS · NCT07582796A Study of BLB-201 RSV Vaccine in Infants and Children
Phase 1/Phase 2 · 16 location(s) · Blue Lake Biotechnology Inc. · NCT05655182Safety of RSV Preventive Monoclonal Antibody
Phase 4 · 6 location(s) · Duke University · NCT07158814A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respirato
Phase 3 · 11 location(s) · University of Witwatersrand, South Africa · NCT06955728Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination
Phase 3 · 1 location(s) · Centre Hospitalier Annecy Genevois · NCT07232706Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Phase 2 · 3 location(s) · Fred Hutchinson Cancer Center · NCT06817889A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)
Phase 1/Phase 2 · 6 location(s) · AstraZeneca · NCT07717840Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia
NA · 2 location(s) · West China Second University Hospital · NCT06881056Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18
Phase 1 · 6 location(s) · Sanofi · NCT07516418A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants
Phase 3 · 18 location(s) · Shanghai Ark Biopharmaceutical Co., Ltd. · NCT06775405Identification and Clinical Validation of Biomarkers Associated With Clinical Severity in Adults Infected With RSV
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06197152A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine
Phase 1/Phase 2 · 2 location(s) · Sinocelltech Ltd. · NCT06754605Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06881953A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.
Phase 2/Phase 3 · 9 location(s) · Shanghai Ark Biopharmaceutical Co., Ltd. · NCT07658534Infant RSV Immunity Study
Phase N/A · 1 location(s) · University of British Columbia · NCT07653347
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.